Location History:
- Hayward, CA (US) (2002 - 2003)
- San Mateo, CA (US) (2004 - 2023)
Company Filing History:
4 out of 11 
1 out of 1,982 
1 out of 27 
Years Active: 2002-2023
Title: The Innovative Contributions of Paul D. Kassner
Introduction
Paul D. Kassner is a notable inventor based in San Mateo, California, recognized for his significant contributions to the field of therapeutic methods and antibody development. With a total of seven patents to his name, Kassner has made strides in addressing critical health issues, particularly in cancer treatment.
Latest Patents
Kassner's latest patents include groundbreaking work on anticancer agents. These patents disclose therapeutic methods for administering compounds that modulate the C–C chemokine receptor type 4 (CCR4) for the treatment of Epstein-Barr virus (EBV) positive cancers and malignancies. Another significant patent focuses on anti-galanin antibodies and their uses. This invention provides antibodies that specifically bind to a galanin peptide, along with methods for preventing, treating, managing, and ameliorating hyperproliferative disorders. The invention also encompasses methods and compositions for diagnosing, monitoring, and prognosing these disorders, as well as articles of manufacture and kits that include these antibodies.
Career Highlights
Throughout his career, Kassner has worked with prominent companies in the biotechnology sector, including Selective Genetics, Inc. and Amgen Inc. His work in these organizations has contributed to the advancement of medical research and therapeutic solutions.
Collaborations
Kassner has collaborated with notable colleagues such as David Larocca and Andrew J. Baird, further enhancing the impact of his innovative work in the field.
Conclusion
Paul D. Kassner's contributions to medical science through his patents and collaborations highlight his role as a significant inventor in the biotechnology industry. His work continues to pave the way for advancements in cancer treatment and therapeutic methods.